233,000 Bottles of Antidepressant Recalled Due to Cancer Risks
The FDA has issued a Class II recall on over 233,000 bottles of duloxetine, a popular antidepressant sold under brand names like Cymbalta and Drizalma. This recall comes after the presence of N-nitroso-duloxetine, a potentially harmful nitrosamine impurity, was detected in certain batches of the drug.
What are Nitrosamines and Why are They Dangerous?
Nitrosamines are organic compounds that can form as byproducts during various industrial processes and can also be found naturally in some foods like cured meats and dairy products.
While trace amounts of nitrosamines are commonly encountered, high levels of exposure over extended periods have been linked to an increased risk of cancer. This has led to numerous recalls of medications and consumer products containing these contaminants in recent years.
What Does This Recall Mean for Patients?
The FDA is urging anyone taking duloxetine to check if their bottles are subject to the recall.
If your medication is affected, it is crucial to stop taking it and consult your healthcare professional about alternative treatment options.
While the FDA classifies the risk as Class II, meaning potentially temporary or reversible health consequences, it is essential to take this recall seriously and prioritize your health.
Looking for More Information?
For more information about the recalled medications and the recall process, please visit the FDA website or USA TODAY’s recall database.
Don’t wait – take action to protect your health. Check your medications today.
